Brief: Cumberland Pharmaceuticals Reports 6% Revenue Growth
10/05/2022 22:58
May 10 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS REPORTS 6% REVENUE GROWTH
* Q1 ADJUSTED EARNINGS PER SHARE $0.03
* QUARTERLY REVENUE $11.2 MILLION
Source text for Eikon: ID:nPn1SHfYza
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM